To compare mineral trioxide aggregate, platelet-rich fibrin, and calcium hydroxide in teeth with irreversible pulpitis: A clinical study

Aim: Numerous pulp-capping agents such as mineral trioxide aggregate (MTA), calcium hydroxide (Ca(OH)2), platelet-rich fibrin (PRF), and biodentine have been suggested. This clinical study was conducted to compare MTA, PRF, and Ca(OH)2 in teeth with irreversible pulpitis. Materials and Methods: The...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy & bioallied science 2020-08, Vol.12 (5), p.436-439
Main Authors: Singh, Revati, Singh, Rohit, Kavita, Kumari, Kommula, Apoorva, Kulkarni, Ganesh, Jois, Harshvardhan
Format: Article
Language:English
Subjects:
Calcium hydroxide
Clinical trials
Dental pulp
Fibrin
Hydroxides
mineral trioxide aggregate
Original
platelet-rich fibrin
Platelets
pulp capping
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim: Numerous pulp-capping agents such as mineral trioxide aggregate (MTA), calcium hydroxide (Ca(OH)2), platelet-rich fibrin (PRF), and biodentine have been suggested. This clinical study was conducted to compare MTA, PRF, and Ca(OH)2 in teeth with irreversible pulpitis. Materials and Methods: The 60 mandibular molar teeth with irreversible pulpitis were used in this study, which were restored with Ca(OH)2, MTA, and PRF. Assessments of the treatment were carried out at 6 months and 1 year by clinical examination and also radiographically. Results: A nonsignificant difference was observed in pain intensity recorded at numerical rating scale at baseline, 24h, 1 week, 1 month, 3 months, 6 months, and 1 year. A nonsignificant (P > 0.05) difference was reported in clinical and radiographic success rate recorded at 6 months and 1 year in all groups. Conclusion: Pulp-capping agents such as Ca(OH)2, MTA, and PRF yielded similar success rate when used in teeth with irreversible pulpitis.
ISSN:0975-7406
0976-4879
0975-7406
DOI:10.4103/jpbs.JPBS_130_20